Expectations trend
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsNASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for PEBK yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
EPS near $3.7 in 2025 | A primary condition in Peoples Bancorp of North Carolina, Inc.'s published investment case. The stated target is >=3.62 USD per share. | Improving | EPS falls below $3.62 in 2025 | Diluted EPS: $1.05 per share FY2026-Q3; GAAP. Published target: >=3.62 USD per share. Annual target cannot be compared with a quarterly or TTM observation. Nov 3, 20261.05 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
PEBK is a financial-sector investment with a multi-year thesis based on consistent profitability and earnings growth. That thesis is currently intact, though the latest quarter was missed and recent earnings surprises have been erratic.
Valuation is above peers, and the expectations gap is slightly negative, meaning expectations appear a little ahead of the model’s view. Valuation rose recently, while the priced-in assessment is tagged as justified and fragility is low.
Recent financial performance is strong relative to the industry, and management is assessed as stable. Near term, the next results remain a risk: the latest quarter was missed, and the estimated chance of another miss is 49%.
The multi-year view depends on maintaining profitability, earnings growth, dividend payments, and strong operating cash flow, all of which are marked for watching. A guidance cut or lower rates could weigh on the near-term setup, while continued strength from financial-sector peers could support sector momentum.
Over the next 1 to 3 years, the thesis is intact but depends on steady execution, with elevated valuation and uneven recent earnings making the next results important. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in Peoples Bancorp of North Carolina, Inc.'s published investment case. The stated target is >=10% YoY. |
| Intact |
| annual revenue growth falls below 7% |
Revenue growth: 4.38% FY2026-Q3; GAAP. Published target: >=10% YoY. Target period is not explicitly aligned with this observation. Nov 3, 20264.382154 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
PE ratio near 11.6 | A supporting condition in Peoples Bancorp of North Carolina, Inc.'s published investment case. The stated target is ~11.5 PE. | Intact | PE ratio rises above 15 or falls below 8 | P/E (TTM): 11.06x As of 2026-11-04; trailing twelve months. The target timing and basis require a separate assessment. Nov 4, 202611.0611 ratio · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.